MK-8892

MK-8892 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MK-8892, covering 2018-10-22 to 2019-07-22. Get the full timeline:

Most recent: Clinical Trial Update: A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001) [Phase 1]

See pricing